应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
EVMN Evommune
休市中 11-13 16:00:00 EST
7.63
-0.39
-4.86%
盘后
7.63
+0.00
0.00%
19:30 EST
最高
8.20
最低
7.45
成交量
72.34万
今开
8.18
昨收
8.02
日振幅
9.41%
总市值
3.15亿
流通市值
1.52亿
总股本
4,135万
成交额
568.15万
换手率
3.64%
流通股本
1,988万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
海创药业:关于签署独家授权许可协议的公告
同花顺 · 11-05
海创药业:关于签署独家授权许可协议的公告
海创药业与Evommune达成VAV1分子胶降解剂海外授权合作
智通财经 · 11-05
海创药业与Evommune达成VAV1分子胶降解剂海外授权合作
Evommune股价大跌11.3%
每日经济新闻 · 09-09
Evommune股价大跌11.3%
Evommune盘前股价下跌18.1%,此前公司研发的湿疹药物未达到中期试验主要终点。
智通财经 · 09-09
Evommune盘前股价下跌18.1%,此前公司研发的湿疹药物未达到中期试验主要终点。
Evommune公布Evo756针对中重度慢性自发性荨麻疹的2b期试验顶线结果
美股速递 · 06-29
Evommune公布Evo756针对中重度慢性自发性荨麻疹的2b期试验顶线结果
加载更多
公司概况
公司名称:
Evommune
所属市场:
NYSE
上市日期:
--
主营业务:
Evommune, Inc.是一家于2020年4月在特拉华州注册成立的公司,总部位于加利福尼亚州的帕洛阿尔托。该公司是一家临床阶段的生物技术公司,专注于针对慢性炎症疾病主要致病因素的创新治疗方案开发。其初步临床开发项目集中在慢性自发性荨麻疹、特应性皮炎和溃疡性结肠炎上。
发行价格:
--
{"stockData":{"symbol":"EVMN","market":"US","secType":"STK","nameCN":"Evommune","latestPrice":7.63,"timestamp":1794603600000,"preClose":8.02,"halted":0,"volume":723351,"hourTrading":{"tag":"盘后","latestPrice":7.63,"preClose":7.63,"latestTime":"19:30 EST","volume":390,"amount":2975.7,"timestamp":1794616206655,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04862842892768076,"floatShares":19882900,"shares":41349900,"eps":-2.609,"marketStatus":"休市中","change":-0.39,"latestTime":"11-13 16:00:00 EST","open":8.18,"high":8.2,"low":7.445,"amount":5681536.848257,"amplitude":0.09414,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.609,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"listingDate":1762405200000,"exchange":"NYSE","adjPreClose":8.02,"postHourTrading":{"tag":"盘后","latestPrice":7.63,"preClose":7.63,"latestTime":"19:30 EST","volume":390,"amount":2975.7,"timestamp":1794616206655,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7697630961500624,"impliedVol":3.0417,"impliedVolPercentile":0.972},"requestUrl":"/m/hq/s/EVMN","defaultTab":"news","newsList":[{"id":"2681276850","title":"海创药业:关于签署独家授权许可协议的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2681276850","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681276850?lang=zh_cn&edition=full","pubTime":"2026-11-05 20:12","pubTimestamp":1793880720,"startTime":"0","endTime":"0","summary":" 证券日报网讯 11月5日,海创药业发布公告称,2026年11月4日,公司与Evommune, Inc.及其全资子公司Evommune MGD, LL ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261105/c681520038.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261105/c681520038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK4139","EVMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681973820","title":"海创药业与Evommune达成VAV1分子胶降解剂海外授权合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2681973820","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681973820?lang=zh_cn&edition=full","pubTime":"2026-11-05 08:29","pubTimestamp":1793838541,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","EVMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666536463","title":"Evommune股价大跌11.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666536463","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666536463?lang=zh_cn&edition=full","pubTime":"2026-09-09 21:49","pubTimestamp":1788961752,"startTime":"0","endTime":"0","summary":"Evommune股价大跌11.3%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609093869583513.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609093869583513.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["EVMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666583066","title":"Evommune盘前股价下跌18.1%,此前公司研发的湿疹药物未达到中期试验主要终点。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666583066","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666583066?lang=zh_cn&edition=full","pubTime":"2026-09-09 16:06","pubTimestamp":1788941171,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["EVMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180323615","title":"Evommune公布Evo756针对中重度慢性自发性荨麻疹的2b期试验顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1180323615","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180323615?lang=zh_cn&edition=full","pubTime":"2026-06-29 20:30","pubTimestamp":1782736249,"startTime":"0","endTime":"0","summary":"Evommune公司宣布了其候选药物Evo756在中重度慢性自发性荨麻疹患者中进行的2b期临床试验的顶线结果。该试验旨在评估Evo756在此类适应症中的疗效与安全性,相关数据为后续临床开发提供了关键依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evommune.com","stockEarnings":[{"period":"1week","weight":0.1474},{"period":"1month","weight":0.3224},{"period":"3month","weight":-0.4792},{"period":"6month","weight":-0.6671},{"period":"1year","weight":-0.5812},{"period":"ytd","weight":-0.5543}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Evommune, Inc.是一家于2020年4月在特拉华州注册成立的公司,总部位于加利福尼亚州的帕洛阿尔托。该公司是一家临床阶段的生物技术公司,专注于针对慢性炎症疾病主要致病因素的创新治疗方案开发。其初步临床开发项目集中在慢性自发性荨麻疹、特应性皮炎和溃疡性结肠炎上。","exchange":"NYSE","name":"Evommune","nameEN":"Evommune"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evommune(EVMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Evommune(EVMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Evommune,EVMN,Evommune股票,Evommune股票老虎,Evommune股票老虎国际,Evommune行情,Evommune股票行情,Evommune股价,Evommune股市,Evommune股票价格,Evommune股票交易,Evommune股票购买,Evommune股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evommune(EVMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Evommune(EVMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}